This DataPack contains 450 tables from Venture Planning Group’s new 7-country study, “Tumor Markers: US, Europe, Japan,” including supplier shares, as well as test volume and sales forecasts for 40 tumor markers. The DataPack will help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global cancer diagnostics market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. Geographic Coverage - France - Germany - Italy - Japan - Spain - UK - USA Market Segmentation Analysis - Sales and market shares of major suppliers, by individual tumor marker and country. - Five-year test volume and sales forecasts for major tumor markers by country and market segment, including: - Hospitals
- Commercial/Private Laboratories
- Physician Offices/Group Practices
- Cancer Clinics
Worldwide Market Overview - Estimated universe of laboratories performing tumor marker testing by country. - Five-year test volume and sales projections by country. Contains 450 tables
|